Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 7, 2009, Pages 1053-1059

  Wang, Huan ^a   Zhang, Weiyu ^a   Tang, Rong ^a   Hebbel, Robert P ^a   Kowalska, M Anna ^b   Zhang, Chunxiang ^a,c   Marth, Jamey D ^d   Fukuda, Minoru ^e   Zhu, Chuhong ^a,c,f   Huo, Yuqing ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BURNHAM INSTITUTE   (United States)

^f CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial recovery; Leukocytes; Neointima formation

Indexed keywords

CORE2 1-6 N GLUCOSAMINYLTRANSFERASE 1; LIGAND; PADGEM PROTEIN; THROMBOCYTE FACTOR 4; TRANSFERASE; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; BETA 1,3 GALACTOSYL O GLYCOSYL GLYCOPROTEIN BETA 1,6 ACETYLGLUCOSAMINYL TRANSFERASE; BETA-1,3-GALACTOSYL-O-GLYCOSYL-GLYCOPROTEIN BETA-1,6-ACETYLGLUCOSAMINYL TRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL INTERACTION; CELL REGENERATION; CONTROLLED STUDY; DRUG TARGETING; HYPERLIPOPROTEINEMIA TYPE 3; INTIMA; LEUKOCYTE; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; ANIMAL; CAROTID ARTERY DISEASE; ENZYMOLOGY; LEUKOCYTE ROLLING; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; RESTENOSIS; THROMBOCYTE ADHESIVENESS;

ANIMALS; APOLIPOPROTEINS E; CAROTID ARTERY DISEASES; CORONARY RESTENOSIS; LEUKOCYTE ROLLING; LEUKOCYTES; MICE; MICE, KNOCKOUT; N-ACETYLGLUCOSAMINYLTRANSFERASES; PLATELET ADHESIVENESS; TUNICA INTIMA;

EID: 67650303106     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.187716     Document Type: Article

References (41)

1. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 1993;21:15-25.
2. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res. 1993;73:792-796.
3. Andrews RK, Shen Y, Gardiner EE, Dong JF, Lopez JA, Berndt MC. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost. 1999;82:357-364.
4. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa - The responsive integrin. Cell. 1991;65:359-362.
5. Manka D, Forlow SB, Sanders JM, Hurwitz D, Bennett DK, Green SA, Ley K, Sarembock IJ. Critical role of platelet P-selectin in the response to arterial injury in apolipoprotein-E- deficient mice. Arterioscler Thromb Vasc Biol. 2004;24:1124-1129.
6. Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/ CD18). J Exp Med. 2000;192:193-204.
7. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res. 2005;96:612-616.
8. McEver RP, Cummings RD. Perspectives series: cell adhesion in vascular biology. role of psgl-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997;100:485-491: 11.
9. Manka D, Collins RG, Ley K, Beaudet AL, Sarembock IJ. Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein E-deficient mice. Circulation. 2001;103:1000-1005.
10. An G, Wang H, Tang R, Yago T, McDaniel JM, McGee S, Huo Y, Xia L. P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation. 2008;117:3227-3237.
11. Phillips JW, Barringhaus KG, Sanders JM, Hesselbacher SE, Czarnik AC, Manka D, Vestweber D, Ley K, Sarembock IJ. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 2003;107:2244-2249.
12. Bienvenu JG, Tanguay JF, Theoret JF, Kumar A, Schaub RG, Merhi Y. Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation. 2001;103:1128-1134.
13. Wang K, Zhou Z, Zhou X, Tarakji K, Topol EJ, Lincoff AM. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. J Am Coll Cardiol. 2001;38:577-582.
14. Norgard KE, Moore KL, Diaz S, Stults NL, Ushiyama S, McEver RP, Cummings RD, Varki A. Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O- linked oligosaccharides. J Biol Chem. 1993;268:12764-12774.
15. Kumar R, Camphausen RT, Sullivan FX, Cumming DA. Core2 beta-1,6-n-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P- selectin. Blood. 1996;88:3872-3879.
16. Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem. 1996; 271:3255-3264.
17. Wang H, Tang R, Zhang W, Amirikian K, Geng Z, Geng J, Hebbel RP, Xia L, Marth JD, Fukuda M, Katoh S, Huo Y. Core2 1- 6-N-Glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2009;29:180-187.
18. Ellies LG, Tsuboi S, Petryniak B, Lowe JB, Fukuda M, Marth JD. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 1998;9: 881-890.
19. Eslin DE, Zhang C, Samuels KJ, Rauova L, Zhai L, Niewiarowski S, Cines DB, Poncz M, Kowalska MA. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood. 2004;104: 3173-3180.
20. Versari D, Lerman LO, Lerman A. The importance of reendothelialization after arterial injury. Curr Pharm Des. 2007;13:1811-1824.
21. Bikfalvi A. Platelet factor 4: an inhibitor of angiogenesis. Semin Thromb Hemost. 2004;30:379-385.
22. Snapp KR, Heitzig CE, Ellies LG, Marth JD, Kansas GS. Differential requirements for the O-linked branching enzyme core 2 beta1-6-N- glucosaminyltransferase in biosynthesis of ligands for E-selectin and P-selectin. Blood. 2001;97:3806-3811.
23. Sperandio M, Thatte A, Foy D, Ellies LG, Marth JD, Ley K. Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase- deficient mice. Blood. 2001;97:3812-3819.
24. Barran P, Fellinger W, Warren CE, Dennis JW, Ziltener HJ. Modification of CD43 and other lymphocyte O-glycoproteins by core 2 N- acetylglucosaminyltransferase. Glycobiology. 1997;7:129-136.
25. Suzuki A, Andrew DP, Gonzalo J-A, Fukumoto M, Spellberg J, Hashiyama M, Suda T, Takimoto H, Gerwin N, Webb J, Gutierrez-Ramos J-C, Molineux G, McNiece I, Ley K, Butcher EC, May WS, Greaves MF, Amakawa R, Tada Y, Wakcham A, Mak TW. CD34 deficient mice have reduced eosinophil accumulation after allergen exposure and reveal a novel crossreactive 90 kD protein. Blood. 1996;87:3550-3562.
26. Carlow DA, Ziltener HJ. CD43 deficiency has no impact in competitive in vivo assays of neutrophil or activated T cell recruitment efficiency. J Immunol. 2006;177:6450-6459.
27. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20: 335-342.
28. Osaka M, Hagita S, Haraguchi M, Kajimura M, Suematsu M, Yoshida M. Real-time imaging of mechanically injured femoral artery in mice reveals a biphasic pattern of leukocyte accumulation. Am J Physiol Heart Circ Physiol. 2007;292:H1876-H1882.
29. Shimazawa M, Watanabe S, Kondo K, Hara H, Nakashima M, Umemura K. Neutrophil accumulation promotes intimal hyperplasia after photochemically induced arterial injury in mice. Eur J Pharmacol. 2005;520: 156-163.
30. Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000;20:2553-2558.
31. Losordo DW, Isner JM, az-Sandoval LJ. Endothelial recovery: the next target in restenosis prevention. Circulation. 2003;107:2635-2637.
32. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 1990;247:77-79.
33. Zucker MB, Katz IR. Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med. 1991;198: 693-702.
34. Smyth SS, Reis ED, Zhang W, Fallon JT, Gordon RE, Coller BS. Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury. Circulation. 2001; 103:2501-2507.
35. LaRosa CA, Rohrer MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD. Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg. 1994;19(2):306-18.
36. Gupta SK, Hassel T, Singh JP. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci U S A. 1995;92:7799-7803.
37. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu- Arg. Proc Natl Acad Sci U S A. 1993;90:3574-3577.
38. von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, Hackeng TM, Weber C. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105:924-930.
39. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med. 2009;15:97-103.
40. Yu G, Rux AH, Ma P, Bdeir K, Sachais BS. Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood. 2005;105: 3545-3551.
41. -/- mice. Thromb Haemost. 2007;98:1108-1113.